Bethel Nutritional Consulting announced a voluntary recall of B-Lipo Capsules, an herbal supplement marketed for weight loss.
After collection and testing done by the Food and Drug Administration (FDA), B-Lipo Capsules were found to contain lorcaserin (marketed as Belviq), a controlled substance used for weight loss. Use of lorcaserin may result in difficulty thinking, hallucinations, feelings of intense excitements, blood sugar changes, and heart rate changes. More severe adverse events include heart valve damage or increased risk of serotonin syndrome if taken with other drugs that work similarly.
The affected B-Lipo Capsules sample has a Lot # 20213, an expiration date of 12/22/2016, and bar code 160126417509. It is packaged in white plastic bottles containing 30 capsules each.
B-Lipo Capsules were sold to customers in retail stores and online. Bethel has discontinued distribution of this product.
For more information call (212) 568-5330 or visit Bethel30.com.